This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Celgene Corporation, Memorial Sloan Kettering Cancer Center. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: The Innovative Contributions of Anna Sophia McKenney
Introduction
Anna Sophia McKenney is a notable inventor based in Selkirk, NY (US). She has made significant contributions to the field of medical treatments, particularly in addressing myeloproliferative neoplasms. With a total of two patents to her name, her work is recognized for its potential impact on patient care.
Latest Patents
McKenney's latest patents focus on methods of treatment for myeloproliferative neoplasms. These patents provide methods and compositions for treating patients carrying both an IDH2 mutation and a JAK2 mutation. Her innovative approaches aim to improve therapeutic outcomes for individuals affected by these conditions.
Career Highlights
Throughout her career, Anna Sophia McKenney has worked with prominent organizations such as Celgene Corporation and Memorial Sloan Kettering Cancer Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of her notable collaborators is Ross L. Levine, who has also made significant contributions to cancer research. Their partnership exemplifies the collaborative spirit that drives innovation in the medical field.
Conclusion
Anna Sophia McKenney's work in developing treatment methods for myeloproliferative neoplasms showcases her dedication to advancing medical science. Her patents and collaborations highlight her role as a key innovator in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile